-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Tag Archives: Ecuador
Latin American states form alliance to tackle investment treaties
Source: SUNS Guayaquil, Ecuador, 23 Apr (Meena Raman) – South American governments have formed a new alliance to fight back against the increasing lawsuits taken against them by transnational companies under bilateral investment treaties. The alliance, known as “the Conference … Continue reading
Ecuador Moves to Annul U.S.-Ecuador BIT, Denounces Investor-State System
Source: Eyes on trade blog by Public Citizen March 14, 2013 As global criticism of the investor-state dispute system mounts, Ecuador is taking concrete steps to secede from pacts that enshrine this system, which exposes the country to direct attacks on its … Continue reading
More on CL issued by Ecuador for life-saving HIV/AIDS treatment to local pharmaceutical firm at Public Citizen
Source: Public Citizen On November 12, 2012, Ecuador issued a second license to promote cost-cutting generic competition for life-saving HIV/AIDS treatments. The government issued the license to Acromax, a firm based in Ecuador, to import and locally produce Glaxo’s patented … Continue reading
Ecuador issues a compulsory license on abacavir/lamivudine on 12 November 2012
Source: KEI Online On 12 November 2012, Ecuador issued a compulsory license on abacavir/lamivudine. This follows the issuance of Ecuador’s first compulsory license in 2009 on ritonavir/lopinavir. In a press release issued by Ecuador’s Institute of Intellectual Property, Ecuador noted … Continue reading